Long-term survival of a patient with scalp angiosarcoma and multiple metastases treated using combination therapy: A case report

Oncology Letters
Jun YeYing Yuan

Abstract

Angiosarcoma is a rare and deadly malignancy originating from the vascular endothelial cells. Surgery is the most effective method to cure this disease, but for metastatic angiosarcoma, a chemotherapy-based treatment is the main therapeutic choice. However, there is currently no standard chemotherapy regimen. The current study reports the case of a 66-year-old male with post-operative scalp angiosarcoma recurrence and multiple metastases. The patient obtained a complete response to first-line combination chemotherapy consisting of cyclophosphamide, epirubicin, vincristine and dacarbazine, with a progression-free survival time of eight months. After benefitting from subsequent comprehensive treatment including, cyclophosphamide, epirubicin, vincristine, dacarbazine, docetaxel, cisplatin, gemcitabine and radiotherapy and anti-angiogenic therapy, the patient obtained an overall survival time of 38 months following initial diagnosis.

References

Feb 15, 1995·Cancer·N NakaK Aozasa
Mar 1, 1996·Journal of Surgical Oncology·N NakaK Aozasa
Dec 31, 1997·The Annals of Otology, Rhinology, and Laryngology·M R AustV J Suman
Oct 2, 2002·Current Oncology Reports·G Thomas Budd
Aug 7, 2003·Seminars in Radiation Oncology·Andy TrottiPhilip Rubin
Jan 1, 1964·The British Journal of Dermatology·E W JONES
Oct 10, 2003·Cancer·Timothy M PawlikVernon K Sondak
Jan 13, 2004·Medical Oncology·Genise FraimanSyed Mehdi
Mar 1, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Vinod RainaGoura K Rath
Mar 16, 2007·Annals of Surgical Oncology·John A AbrahamSam S Yoon
Nov 3, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J FayetteJ Y Blay
Nov 6, 2007·Annales de dermatologie et de vénéréologie·E VerdierP Joly
Jan 13, 2009·Cancer Letters·Hong-Qing Zhuang, Zhi-Yong Yuan
May 20, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert G MakiGary K Schwartz
Jun 25, 2009·Annals of Surgical Oncology·G LahatD Lev
Jun 12, 2010·The Lancet Oncology·Robin J YoungPenella J Woll
Aug 23, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M AgulnikR S Benjamin

❮ Previous
Next ❯

Citations

Apr 20, 2017·NPJ Precision Oncology·Michael J WagnerAnil K Sood
Oct 16, 2019·Oncology Letters·Yong ZhangJiaqi Liu
Jul 5, 2021·International Journal of Surgery Case Reports·Mohammad GilaniLeaque Ahmed

❮ Previous
Next ❯

Methods Mentioned

BETA
dissection
X-ray
biopsy

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.